Clinical trial

Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain

NCT05598736

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-11-04

PhaseNA

Study timeline

Study start (actual)2022-11-04Date precision: day

Registry last updated2023-02-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Spasticity, Muscleunresolved

Painunresolved

Interventions

FlowOx 2.0DEVICE

Sponsors & collaborators

Otivio ASlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05598736 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.